Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2025-12-27 @ 3:58 PM
Study NCT ID:
NCT06922656
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-08-29
First Post:
2025-04-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration?
Sponsor:
Dasman Diabetes Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-09-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-01-15
Completion Date Type:
ESTIMATED
First Submit Date:
2025-04-03
First Submit QC Date:
None
Study First Post Date:
2025-04-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-24
Last Update Post Date:
2025-08-29
Last Update Post Date Type:
ESTIMATED